Lentiviral-mediated interleukin-4 and interleukin-13 RNA interference decrease airway inflammation and hyperresponsiveness

Human Gene Therapy

Volumn 22, Issue 5, 2011, Pages 577-586

  Lee, Chen Chen ^a   Huang, Hsin Ying ^b   Chiang, Bor Luen ^b,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; LENTIVIRUS VECTOR; OVALBUMIN; SHORT HAIRPIN RNA;

AIRWAY HYPERRESPONSIVENESS; AIRWAY INFLAMMATION; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BODY PLETHYSMOGRAPHY; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNIZATION; LUNG RESISTANCE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; RNA INTERFERENCE; SENSITIZATION; TH2 CELL;

ANIMALS; ASTHMA; GENE THERAPY; GENETIC VECTORS; INTERLEUKIN-13; INTERLEUKIN-4; LENTIVIRUS; MICE; OVALBUMIN; RNA INTERFERENCE; RNA, SMALL INTERFERING;

MURINAE; MUS;

EID: 79955402279     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.105     Document Type: Article

References (40)

1. Abbas-Terki, T., Blanco-Bose, W., Deglon, N., et al. (2002). Lentiviral-mediated RNA interference. Hum. Gene Ther. 13, 2197-2201. (Pubitemid 36418813)
2. Alisky, J.M., and Davidson, B.L. (2004). Towards therapy using RNA interference. Am. J. Pharmacogenomics 4, 45-51. (Pubitemid 38325704)
3. Barnes, P.J. (2000). Mechanisms in COPD: differences from asthma. Chest 117, 10S-14S. (Pubitemid 30111557)
4. Barnes, P.J. (2003). Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev. 14, 511-522. (Pubitemid 37296024)
5. Bridge, A.J., Pebernard, S., Ducraux, A., et al. (2003). Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264. (Pubitemid 36792856)
6. Chung, K.F., and Barnes, P.J. (1999). Cytokines in asthma. Thorax 54, 825-857. (Pubitemid 29401546)
7. Economides, A.N., Carpenter, L.R., Rudge, J.S., et al. (2002). Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat. Med. 9, 47-52. (Pubitemid 36098259)
8. Fu, C.L., Ye, Y.L., Lee, Y.L., and Chiang, B.L. (2006). Effects of overexpression of IL-10, IL-12, TGF-beta and IL-4 on allergen induced change in bronchial responsiveness. Respir. Res. 7, 72.
9. Gessner, A., Mohrs, K., and Mohrs, M. (2005). Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J. Immunol. 174, 1063-1072. (Pubitemid 40094303)
10. Glaab, T., Mitzner, W., Braun, A., et al. (2004). Repetitive measurements of pulmonary mechanics to inhaled cholinergic challenge in spontaneously breathing mice. J. Appl. Physiol. 97, 1104-1111. (Pubitemid 39121439)
11. Hamelmann, E., Schwarze, J., Takeda, A., et al. (1997). Non-invasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care 156, 766-775. (Pubitemid 27396413)
12. Harp, J.B. (2004). New insights into inhibitors of adipogenesis. Curr. Opin. Lipidol. 15, 303-307. (Pubitemid 38716563)
13. Hocke, A.C., Ermert, M., Althoff, A., et al. (2006). Regulation of interleukin IL-4, IL-13, IL-10, and their downstream components in lipopolysaccharide-exposed rat lungs. Comparison of the constitutive expression between rats and humans. Cyto-kine 33, 199-211.
14. Huang, H.Y., Lee, C.C., and Chiang, B.L. (2008). Small interfering RNA against interleukin-5 decreases airway eosinophilia and hyper-responsiveness. Gene Ther. 15, 660-667.
15. Iwakuma, T., Cui, Y., and Chang, L.J. (1999). Self-inactivating lentiviral vectors with U3 and U5 modifications. Virology 264, 120-132.
16. Jackson, X., et al. (2003). Expression profiling reveals off target gene regulation by RNA. Nat. Biotechnol. 21, 635-637.
17. Karras, J.G., Crosby, J.R., Guha, M., et al. (2007). Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice. Am. J. Respir. Cell Mol. Biol. 36, 276-285. (Pubitemid 46365278)
18. Kips, J.C., O'Connor, B.J., Langley S.J., et al. (2003). Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma. Am. J. Respir. Cell Mol. Biol. 167, 1655-1659. (Pubitemid 36760679)
19. Kumar, R.K., Herbert, C., Webb, D.C., et al. (2004). Effects of anticytokine therapy in a mouse model of chronic asthma. Am. J. Respir. Crit. Care Med. 170, 1043-1048. (Pubitemid 39488615)
20. Kuperman, D.A., and Schleimer, R.P. (2008). Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr. Mol. Med. 8, 384-392.
21. Lamkhioued, B., Abdelilah, S.G., Hamid, Q., et al. (2003). The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34\+progenitor cells. J. Immunol. 170, 537-547. (Pubitemid 36026181)
22. LaVoie, H.A. (2003). The role of GATA in mammalian reproduction. Exp. Biol. Med. (Maywood) 228, 1282-1290.
23. Leckie, M.J., ten Brinke, A., Khan, J., et al. (2000). Effects of an interleukin-5 blocking antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356, 2144-2148.
24. Lee, C.C., Huang, H.Y., and Chiang, B.L. (2008). Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol. Ther. 16, 60-65.
25. Miyabara, Y., Yanagisawa, R., Shimojo, N., et al. (1998). Murine strain differences in airway inflammation caused by diesel exhaust particles. Eur. Respir. J. 11, 291-298. (Pubitemid 28108338)
26. Molet, S., Ramos-Barbon, D., Martin, J.G., and Hamid, Q. (1999). Adoptively transferred late allergic response is inhibited by IL-4, but not IL-5, antisense oligonucleotide. J. Allergy Clin. Immunol. 104, 205-214. (Pubitemid 29364506)
27. Mori, A., Ogawa, K., Kajiyama, Y., et al. (2006). Th2-cell-mediated chemokine synthesis is involved in allergic airway inflammation in mice. Int. Arch. Allergy Immunol. 140(Suppl. 1), 55-58. (Pubitemid 43882386)
28. Pebernard, S., and Iggo, R. (2004). Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 72, 103-111. (Pubitemid 41702145)
29. Persengiev, S.P., Zhu, X., and Green, M.R. (2004). Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12-18. (Pubitemid 38018731)
30. Rubinson, D.A., Dillon, C.P., Kwiatkowski, A.V., et al. (2003). Lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401-406. (Pubitemid 36278858)
31. Schnyder, B., Lugli, S., Feng, N., et al. (1996). Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endo-thelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood 87, 4286-4295. (Pubitemid 26152270)
32. Shore, S.A. (2004). Direct effects of Th2 cytokines on airway smooth muscle. Curr. Opin. Pharmacol. 4, 235-240. (Pubitemid 38585307)
33. Ting, C.N., Olson, M.C., Barton, K.P., and Leiden, J.M. (1996). Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384, 474-478.
34. Tomar, R.S., Matta, H., and Chaudhary, P.M. (2003). Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene 22, 5712-5715. (Pubitemid 37102709)
35. Turner, P.J., and Foreman, J.C. (1999). Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease. Mediators Inflamm. 8, 133-146. (Pubitemid 29332052)
36. Venkayya, R., Lam, M., Willkom, M., et al. (2002). The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am. J. Respir. Cell Mol. Biol. 26, 202-208. (Pubitemid 34107874)
37. Wills-Karp, M. (1999). Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255-281. (Pubitemid 29241125)
38. Yang, G., Volk, A., Petley, T., et al. (2004). Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 28, 224-232. (Pubitemid 39573497)
39. Yang, M., Rangasamy, D., Matthaei, K.I., et al. (2006). Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J. Immunol. 177, 5595-5603. (Pubitemid 44527634)
40. Zavorotinskaya, T., Tomkinson, A., and Murphy, J.E. (2003). Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13. Mol. Ther. 7, 155-162. (Pubitemid 36395350)